Search in:

Future Science OA Volume 1, 2015 - Issue 4

Submit an article Journal homepage

Open access

1,521

Views

CrossRef citations to date

Altmetric

Case Report

Clinical activity of regorafenib in PDGFRA-mutated gastrointestinal stromal tumor

Thomas Grellety1 Department of Medical Oncology, Institut Bergonié, Bordeaux, FranceView further author information

Michèle Kind2 Department of Radiology, Institut Bergonié, Bordeaux, FranceView further author information

Jean-Michel Coindre3 Department of Pathology, Institut Bergonié, Bordeaux, FranceView further author information

Antoine Italiano1 Department of Medical Oncology, Institut Bergonié, Bordeaux, FranceCorrespondence[email protected]
View further author information

Article: FSO33 | Published online: 24 Jun 2015

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (10)

Newton A.C.S. Wong, Christel Garcia-Petit, Adam Dangoor & Nicola Andrew. (2022) A literature review and database of how the primary KIT/PDGFRA variant of a gastrointestinal stromal tumour predicts for sensitivity to imatinib. Cancer Genetics 268-269, pages 46-54.
Crossref

Yingchao Sun, Lei Yue, Pengfu Xu & Weiling Hu. (2022) An overview of agents and treatments for PDGFRA-mutated gastrointestinal stromal tumors. Frontiers in Oncology 12.
Crossref

Soon‐Chan Kim, Ji Won Park, Ha‐Young Seo, Minjung Kim, Jae‐Hyeon Park, Ga‐Hye Kim, Ja Oh Lee, Young‐Kyoung Shin, Jeong Mo Bae, Bon‐Kyoung Koo, Seung‐Yong Jeong & Ja‐Lok Ku. (2021) Multifocal Organoid Capturing of Colon Cancer Reveals Pervasive Intratumoral Heterogenous Drug Responses. Advanced Science 9:5.
Crossref

A. Trullas-Jimeno, J. Delgado, B. Garcia-Ochoa, I. Wang, A. Sancho-Lopez, C. Payares-Herrera, M.L. Dalhus, B.O. Strøm, E.J. Egeland, H. Enzmann & F. Pignatti. (2021) The EMA assessment of avapritinib in the treatment of gastrointestinal stromal tumours harbouring the PDGFRA D842V mutation. ESMO Open 6:3, pages 100159.
Crossref

Jean-Yves Blay, Yoon-Koo Kang, Toshiroo Nishida & Margaret von Mehren. (2021) Gastrointestinal stromal tumours. Nature Reviews Disease Primers 7:1.
Crossref

Daria A. Filonenko, Bela M. Medvedeva & Andrey A. Meshcheryakov. (2021) Avapritinib: a new tyrosine kinase inhibitor for treatment of advanced gastrointestinal stromal tumors. The literature review and clinical case. Journal of Modern Oncology 22:4, pages 96-100.
Crossref

Alessandro Rizzo, Maria Abbondanza Pantaleo, Annalisa Astolfi, Valentina Indio & Margherita Nannini. (2021) The Identity of PDGFRA D842V-Mutant Gastrointestinal Stromal Tumors (GIST). Cancers 13:4, pages 705.
Crossref

D. A. Filonenko, S. V. Petukhova, E. I. Khatkova, K. A. Vorontsova, E. I. Chichikov, B. M. Medvedeva & L. G. Zhukova. (2018) The use of regorafenib in patients with disseminated gastrointestinal stromal tumours. A review of the literature. A clinical case. Medical Council:10, pages 12-16.
Crossref

Gregory W. Charville & Teri A. Longacre. (2017) Surgical Pathology of Gastrointestinal Stromal Tumors: Practical Implications of Morphologic and Molecular Heterogeneity for Precision Medicine. Advances in Anatomic Pathology 24:6, pages 336-353.
Crossref

. (2017) Regorafenib. Reactions Weekly 1646:1, pages 292-292.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Clinical activity of regorafenib in PDGFRA-mutated gastrointestinal stromal tumor

Articles from other publishers (10)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Clinical activity of regorafenib in PDGFRA-mutated gastrointestinal stromal tumor

Citations (10)

Articles from other publishers (10)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date